NCT05903807View on ClinicalTrials.gov

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2035

Conditions
Ovarian Cancer
Interventions
DRUG

68Ga-FAPi-46

Ovarian cancer patients undergo 68Ga-FAPI-46 at primary staging and at restaging

Trial Locations (1)

9000

RECRUITING

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Aalborg University Hospital

OTHER